These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 8296100

  • 1. [Antimicrobial activity of amoxicillin versus amoxicillin/clavulanic acids. In vitro study against S aureus, H influenzae and A baumanii strains].
    Trucco O, Prado V, Garreaud C, Paya E.
    Rev Med Chil; 1993 Aug; 121(8):916-22. PubMed ID: 8296100
    [Abstract] [Full Text] [Related]

  • 2. [In vitro comparative activity of moxifloxacin and other antimicrobials against respiratory pathogens].
    Prado V, Giangrieco M, Durán C, Ojeda A, van Flaskamp R.
    Rev Med Chil; 2000 Dec; 128(12):1319-26. PubMed ID: 11227240
    [Abstract] [Full Text] [Related]

  • 3. [Activity of the amoxicillin-clavulanic acid (augmentin) combination on strains of hospital isolates].
    Deforges L, Le Van Thoi J, Soussy CJ, Duval J.
    Pathol Biol (Paris); 1985 May; 33(5):301-8. PubMed ID: 3929215
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Effect of the amoxicillin-gentamicin combination in the presence of clavulanic acid on 8 strains of amoxicillin-resistant bacteria].
    Deforges L, Soussy CJ, Duval J.
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):496-500. PubMed ID: 6379567
    [Abstract] [Full Text] [Related]

  • 6. Exacerbation of COPD: amoxicillin + clavulanic acid in vitro activity vs S. pneumoniae, H. influenzae and M. catarrhalis.
    Beghi G, Legnani D, De Bartolo A, Pagani N, Lusco G.
    J Chemother; 1995 Nov; 7 Suppl 4():61-2. PubMed ID: 8904109
    [No Abstract] [Full Text] [Related]

  • 7. [Bactericidal effect of cefadroxil, amoxicillin alone or in combination with clavulanic acid in sera of healthy volunteers].
    Etesse-Carsenti H, Garraffo R, Bernard E, de Salvador F, Pradier C, Durant J, Mondain V, Drugeon HB, Dellamonica P.
    Pathol Biol (Paris); 1991 Dec; 39(10):972-7. PubMed ID: 1805138
    [Abstract] [Full Text] [Related]

  • 8. [Bactericide activity of cefadroxil comparated with amoxicillin-clavulanic acid, cefaclor and josamycin].
    Etesse-Carsenti H, Caillon J, Mondain V, Durant J, Bernard E, Dellamonica P, Drugeon HB.
    Pathol Biol (Paris); 1991 Sep; 39(7):658-67. PubMed ID: 1758716
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The antibacterial activity of amoxycillin/clavulanic acid against Staphylococcus aureus ingested by human granulocytes.
    Cuffini AM, Tullio V, Allocco A, Paizis G, Carlone NA.
    Microbios; 1996 Sep; 87(350):31-8. PubMed ID: 8972100
    [Abstract] [Full Text] [Related]

  • 12. [Ampicillin-sulbactam activity against respiratory isolates of Haemophilus influenzae].
    Cisterna R, Fresnadillo MJ, García-Rodríguez JA, Gobernado M, Martín R, Perea E, Picazo J.
    Rev Esp Quimioter; 1998 Sep; 11(3):245-50. PubMed ID: 9795311
    [Abstract] [Full Text] [Related]

  • 13. Influence of different resistance traits on the competitive growth of Haemophilus influenzae in antibiotic-free medium and selection of resistant populations by different {beta}-lactams: an in vitro pharmacodynamic approach.
    González N, Aguilar L, Alou L, Giménez MJ, Sevillano D, Torrico M, Cafini F, Coronel P, Prieto J.
    J Antimicrob Chemother; 2009 Jun; 63(6):1215-22. PubMed ID: 19307171
    [Abstract] [Full Text] [Related]

  • 14. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000.
    Koeth LM, Jacobs MR, Good CE, Bajaksouzian S, Windau A, Jakielaszek C, Saunders KA.
    Int J Infect Dis; 2004 Nov; 8(6):362-73. PubMed ID: 15494258
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro bactericidal activity of peak serum concentrations of co-amoxiclav, amoxicillin and vancomycin against methicillin-resistant Staphylococcus aureus.
    Gómez-Lus ML, Prieto J, Giménez MJ, García M, Anta L, Aguilar L.
    Rev Esp Quimioter; 1999 Jun; 12(2):136-9. PubMed ID: 10562674
    [Abstract] [Full Text] [Related]

  • 18. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
    Jacobs E, Dalhoff A, Korfmann G.
    Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
    [Abstract] [Full Text] [Related]

  • 19. [Kinetics of ofloxacin-amoxicillin and ofloxacin-clavulanic acid combinations against pathogenic bacteria of the respiratory tract].
    Caillon J, Juvin ME, Pirault JL, Drugeon HB.
    Pathol Biol (Paris); 1988 May; 36(5):414-9. PubMed ID: 3043337
    [Abstract] [Full Text] [Related]

  • 20. Detection of borderline oxacillin-resistant Staphylococcus aureus and differentiation from methicillin-resistant strains.
    Liu H, Buescher G, Lewis N, Snyder S, Jungkind D.
    Eur J Clin Microbiol Infect Dis; 1990 Oct; 9(10):717-24. PubMed ID: 2261916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.